The clinical symptoms of Parkinson's disease

S Sveinbjornsdottir - Journal of neurochemistry, 2016 - Wiley Online Library
In this review, the clinical features of Parkinson's disease, both motor and non‐motor, are
described in the context of the progression of the disease. Also briefly discussed are the …

[HTML][HTML] Electrodiagnostic assessment of the autonomic nervous system: a consensus statement endorsed by the American Autonomic Society, American Academy of …

WP Cheshire, R Freeman, CH Gibbons, P Cortelli… - Clinical …, 2021 - Elsevier
Abstract Evaluation of disorders of the autonomic nervous system is both an art and a
science, calling upon the physician's most astute clinical skills as well as knowledge of …

Heart–brain axis: effects of neurologic injury on cardiovascular function

P Tahsili-Fahadan, RG Geocadin - Circulation research, 2017 - Am Heart Assoc
A complex interaction exists between the nervous and cardiovascular systems. A large
network of cortical and subcortical brain regions control cardiovascular function via the …

A new treatment strategy for Parkinson's disease through the gut–brain axis: the glucagon-like peptide-1 receptor pathway

DS Kim, HI Choi, Y Wang, Y Luo, BJ Hoffer… - Cell …, 2017 - journals.sagepub.com
Molecular communications in the gut–brain axis, between the central nervous system and
the gastrointestinal tract, are critical for maintaining healthy brain function, particularly in …

Climate change and neurodegenerative diseases

P Bongioanni, R Del Carratore, S Corbianco… - Environmental …, 2021 - Elsevier
The climate change induced global warming, and in particular the increased frequency and
intensity of heat waves, have been linked to health problems. Among them, scientific works …

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets

AJ Espay, PA LeWitt, RA Hauser, A Merola… - The Lancet …, 2016 - thelancet.com
Neurogenic orthostatic hypotension and supine hypertension are common manifestations of
cardiovascular dysautonomia in Parkinson's disease and related synucleinopathies …

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled …

P Novak, DA Pimentel Maldonado, V Novak - PloS one, 2019 - journals.plos.org
Parkinson disease (PD) is associated with cognitive impairment. We aimed to determine the
effects of intranasal insulin (INI) on cognition and motor performance in PD. This was a proof …

Premotor signs and symptoms of multiple system atrophy

M Jecmenica-Lukic, W Poewe, E Tolosa… - The Lancet …, 2012 - thelancet.com
Diagnostic criteria for multiple system atrophy are focused on motor manifestations of the
disease, in particular ataxia and parkinsonism, but these criteria often cannot detect the …

Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease

E Stuebner, E Vichayanrat, DA Low, CJ Mathias… - Frontiers in …, 2013 - frontiersin.org
Non-motor symptoms are now commonly recognized in Parkinson's disease (PD) and can
include dysautonomia. Impairment of cardiovascular autonomic function can occur at any …

The potential prognostic role of cardiovascular autonomic failure in α‐synucleinopathies

A Fanciulli, S Strano, C Colosimo… - European Journal of …, 2013 - Wiley Online Library
Cardiovascular autonomic failure is the second most common dysautonomic feature of α‐
synucleinopathies and has significant impact on daily activities and quality of life. Here we …